Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: chemistry – Page 262

Researchers propose dual-plating strategy to rapidly construct microbatteries

High-performance, micro-sized electrochemical energy storage devices are essential for future miniaturized electronic devices, such as smart medical implants, wireless sensors, and the Internet of Things. Microbatteries (MBs) typically show higher energy density and more stable voltage output than micro-supercapacitors.

However, current MBs involve tedious construction procedures and unsatisfactory electrochemical performance. In addition, no methods exist to construct or manipulate a liquid microelectrode.

A joint research team led by Prof. Qu Liangti from Tsinghua University, Prof. Zhang Zhipan from the Beijing Institute of Technology, and Prof. Liu Feng from the Institute of Mechanics of the Chinese Academy of Sciences (IMCAS) recently proposed a dual-plating strategy to rapidly construct new zinc–bromine microbatteries (Zn–Br2 MBs) with ultrahigh areal and polarity-switchable functionality.

MIT Professor Wins European Inventor Award for Liquid Metal Batteries

For his work on liquid metal batteries that could enable the long-term storage of renewable energy, MIT Professor Donald Sadoway has won the 2022 European Inventor Award, in the category for Non-European Patent Office Countries.

Sadoway is a longtime supporter and friend of MIT’s Materials Research Laboratory and is the John F. Elliott Professor of Materials Chemistry in MIT’s Department of Materials Science and Engineering.

“By enabling the large-scale storage of renewable energy, Donald Sadoway’s invention is a huge step towards the deployment of carbon-free electricity generation,” says António Campinos, President of the European Patent Office. “He has spent his career studying electrochemistry and has transformed this expertise into an invention that represents a huge step forward in the transition to green energy.”

MIT’s Raman Lab: At the Forefront of Building With Biology

Ritu Raman leads the Raman Lab, where she creates adaptive biological materials for applications in medicine and machines.

It seems that Ritu Raman was born with an aptitude for engineering. You may say it is in her blood since her mother is a chemical engineer, her father is a mechanical engineer, and her grandfather is a civil engineer. Throughout her childhood, she repeatedly witnessed firsthand the beneficial impact that engineering careers could have on communities. In fact, watching her parents build communication towers to connect the rural villages of Kenya to the global infrastructure is one of her earliest memories. She still vividly remembers the excitement she felt watching the emergence of a physical manifestation of innovation that would have a long-lasting positive impact on the community.

Raman is “a mechanical engineer through and through,” as she puts it. She earned her BS, MS, and PhD in mechanical engineering. Her postdoctoral work at MIT.

Bacteria-based biohybrid microrobots on a mission to one day battle cancer

A team of scientists in the Physical Intelligence Department at the Max Planck Institute for Intelligent Systems have combined robotics with biology by equipping E. coli bacteria with artificial components to construct biohybrid microrobots. First, as can be seen in Figure 1, the team attached several nanoliposomes to each bacterium. On their outer circle, these spherical-shaped carriers enclose a material (ICG, green particles) that melts when illuminated by near infrared light. Further towards the middle, inside the aqueous core, the liposomes encapsulate water soluble chemotherapeutic drug molecules (DOX).

The second component the researchers attached to the bacterium is . When exposed to a magnetic field, the iron oxide particles serve as an on-top booster to this already highly motile microorganism. In this way, it is easier to control the swimming of —an improved design toward an in vivo application. Meanwhile, the rope binding the liposomes and magnetic particles to the bacterium is a very stable and hard to break streptavidin and biotin complex, which was developed a few years prior and reported in a Nature article, and comes in useful when constructing biohybrid microrobots.

E. coli bacteria are fast and versatile swimmers that can navigate through material ranging from liquids to highly viscous tissues. But that is not all, they also have highly advanced sensing capabilities. Bacteria are drawn to chemical gradients such as or high acidity—both prevalent near tumor tissue. Treating cancer by injecting bacteria in proximity is known as bacteria mediated tumor therapy. The microorganisms flow to where the tumor is located, grow there and in this way activate the immune system of patients. Bacteria mediated tumor therapy has been a therapeutic approach for more than a century.

Providing embedded artificial intelligence with a capacity for palimpsest memory storage

Biological synapses are known to store multiple memories on top of each other at different time scales, much like representations of the early techniques of manuscript writing known as “palimpsest,” where annotations can be superimposed alongside traces of earlier writing.

Biological palimpsest consolidation occurs via hidden that govern synaptic efficacy at varying lifetimes. The arrangement can facilitate idle memories to be overwritten without forgetting them, while using previously unseen memories short-term. Embedded can significantly benefit from such functionality; however, the hardware has yet to be demonstrated in practice.

In a new report, now published in Science Advances, Christos Giotis and a team of scientists in Electronics and Computer Science at the University of Southampton and the University of Edinburgh, U.K., showed how the intrinsic properties of metal-oxide volatile memristors mimicked the process of biological palimpsest consolidation.

Geological activity can rapidly change deep microbial communities

In the deep subsurface that plunges into the Earth for miles, microscopic organisms inhabit vast bedrock pores and veins. Belowground microorganisms, or microbes, comprise up to half of all living material on the planet and support the existence of all life forms up the food chain. They are essential for realizing an environmentally sustainable future and can change the chemical makeup of minerals, break down pollutants, and alter the composition of groundwater.

While the significance of bacteria and archaea is undeniable, the only evidence of their existence in the deep comes from traces of biological material that seep through mine walls, cave streams, and drill holes that tap into aquifers.

Many scientists have assumed that the composition of microbial communities in the deep subsurface is primarily shaped by local environmental pressures on microbial survival such as temperature, acidity, and oxygen concentration. This process, environmental selection, can take years to millennia to cause significant community-level changes in slow-growing communities like the subsurface.

Dr. Stephen Moran, PhD — Reimagining Nuclear Medicine — Advanced Accelerator Applications, Novartis

Reimagining Nuclear Medicine — Dr. Stephen Moran, Ph.D., Global Program Head, Neuroendocrine Tumors & Other Radiosensitive Cancers, Advanced Accelerator Applications, Novartis

Dr. Stephen Moran, Ph.D., is Global Program Head, Neuroendocrine Tumors & Other Radiosensitive Cancers, for Advanced Accelerator Applications (AAA — https://www.adacap.com/), a Novartis company and also a member of the Oncology Development Unit Leadership Team at Novartis.

Prior to joining AAA, Dr. Moran was Global Head of Novartis Strategy, where he played a key role in defining the company’s strategy, prioritizing critical actions needed to deliver on the mission to discover new ways to extend and improve peoples’ lives. He also led numerous strategic initiatives, including gene therapy (AveXis, now Novartis Gene Therapies), RNA therapeutics (The Medicines Company), precision medicine and digital strategies.

Dr. Moran joined Novartis as Strategic Assistant to the CEO, a position he held for two years and prior to this, he was an associate principal at McKinsey & Company serving as a leader in the healthcare practice, where he focused on health system sustainability, research and development strategy, and the economic analysis of clinical interventions across disease pathways.

Dr. Moran holds a Bachelor of Arts and a Master of Science in Biochemistry from the University of Cambridge in the United Kingdom, including an undergraduate exchange program at the Massachusetts Institute of Technology (MIT). He also received a Doctorate from the University of Oxford in Biophysics where he lectured on thermodynamics, quantum mechanics and electromagnetism as applied to biology.

Continue reading “Dr. Stephen Moran, PhD — Reimagining Nuclear Medicine — Advanced Accelerator Applications, Novartis” | >

Researchers find the missing photonic link to enable an all-silicon quantum internet

Researchers at Simon Fraser University have made a crucial breakthrough in the development of quantum technology.

Their research, published in Nature today, describes their observations of more than 150,000 silicon “T center” photon-spin qubits, an important milestone that unlocks immediate opportunities to construct massively scalable quantum computers and the quantum internet that will connect them.

Quantum computing has to provide computing power well beyond the capabilities of today’s supercomputers, which could enable advances in many other fields, including chemistry, , medicine and cybersecurity.

UK’s first industrial-scale carbon capture and usage plant

The plant seen here will capture 40,000 tonnes of carbon dioxide (CO2) each year – 100 times more than the UK’s current largest facility and equivalent to taking 20,000 cars off the roads. The £20 million investment has been completed by Northwich-based Tata Chemicals Europe, one of Europe’s leading producers of sodium carbonate, salt and sodium bicarbonate.

The project will help to unlock the future of carbon capture and utilisation, as it proves the viability of the technology at a large scale, removing CO2 from gas power plant emissions for use in high-end manufacturing applications.

In a world-first, the captured emissions are being purified to food and pharmaceutical grade, then used as raw material for a form of sodium bicarbonate that will be known as Ecokarb. This unique and innovative manufacturing process is patented in the UK, with further patents pending in key territories around the world. Ecokarb will be exported to more than 60 countries.